We are live on ! Find out more
MD icon

Pediatrix Medical

320 hedge funds and large institutions have $4.14B invested in Pediatrix Medical in 2018 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 109 increasing their positions, 117 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more call options, than puts

Call options by funds: $5.45M | Put options by funds: $4.88M

6% more capital invested

Capital invested by funds: $3.91B → $4.14B (+$232M)

5% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 42

0.61% less ownership

Funds ownership: 95.5%94.89% (-0.61%)

1% less funds holding

Funds holding: 322320 (-2)

7% less repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 117

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
320
Holders Change
-2
Holders Change %
-0.62%
% of All Funds
7.31%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
44
Increased
109
Reduced
117
Closed
42
Calls
$5.45M
Puts
$4.88M
Net Calls
+$578K
Net Calls Change
-$3.93M
Name Holding Trade Value Shares
Change
Change in
Stake
Balyasny Asset Management
326
Balyasny Asset Management
Illinois
-$4.98M -115,049 Closed
Nomura Holdings
327
Nomura Holdings
Japan
-$4.56M -105,302 Closed
LG
328
Leuthold Group
Minnesota
-$3.89M -89,914 Closed
EGM
329
Engineers Gate Manager
New York
-$3.08M -71,236 Closed
FPA
330
First Pacific Advisors
California
-$2.45M -56,570 Closed
Brown Advisory
331
Brown Advisory
Maryland
-$2.05M -47,466 Closed
Arrowstreet Capital
332
Arrowstreet Capital
Massachusetts
-$1.94M -44,800 Closed
AIMCA
333
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
-$1.89M -43,600 Closed
GAM
334
Gotham Asset Management
New York
-$1.83M -42,306 Closed
UH
335
Unigestion Holding
Switzerland
-$1.74M -40,200 Closed
Envestnet Asset Management
336
Envestnet Asset Management
Illinois
-$1.27M -29,281 Closed
Truist Financial
337
Truist Financial
North Carolina
-$1.21M -27,864 Closed
ZIM
338
Zacks Investment Management
Illinois
-$1.19M -27,380 Closed
RIM
339
Redwood Investment Management
Arizona
-$1.08M -24,898 Closed
SCA
340
Secor Capital Advisors
New York
-$978K -22,587 Closed
BRCM
341
Bright Rock Capital Management
Massachusetts
-$892K -20,600 Closed
CP
342
Cumberland Partners
Ontario, Canada
-$649K -15,000 Closed
IG
343
ING Group
Netherlands
-$626K -14,474 Closed
BTS
344
BB&T Securities
Virginia
-$509K -11,768 Closed
Cerity Partners
345
Cerity Partners
New York
-$449K -10,364 Closed
DCM
346
Dynamic Capital Management
Jersey
-$410K -9,468 Closed
SSA
347
Schonfeld Strategic Advisors
New York
-$347K -8,027 Closed
QC
348
Quadrature Capital
United Kingdom
-$332K -7,677 Closed
GIA
349
Gargoyle Investment Advisor
New Jersey
-$324K -7,489 Closed
CT
350
Chicago Trust
Illinois
-$283K -6,557 Closed

MD Hedge Fund Activity: Q3 2018 in Review

320 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q3 2018, worth a combined $4.14B — up 5.9% from $3.91B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new MD positions and 42 closed out — a net gain of 2 holders — while 109 added to existing stakes and 117 trimmed.

The largest buyer was Pzena Investment Management, adding an estimated $43.8M. The largest seller was Thompson Siegel & Walmsley, cutting an estimated $64.8M.

  • 320 institutional investors held Pediatrix Medical (MD) as of Q3 2018, down from 322 in Q2 2018.
  • Funds reported $4.14B of Pediatrix Medical stock for Q3 2018, up 5.9% quarter-over-quarter.
  • 44 funds opened new Pediatrix Medical positions in Q3 2018 and 42 closed out, a net change of +2 holders.
  • The largest Pediatrix Medical buyer in Q3 2018 was Pzena Investment Management, an estimated $43.8M added.
  • The largest Pediatrix Medical seller in Q3 2018 was Thompson Siegel & Walmsley, an estimated $64.8M sold.

Based on aggregated 13F filings for Q3 2018.